We've been taking a look at the idea of using human challenge trials, intentionally infecting volunteers in a controlled study, to speed up development of a vaccine for the coronavirus. In Part 1, we talked to the Rutgers Bioethicist who co-authored a paper advocating for the use of challenge trials for a coronavirus vaccine. In Part 2, we talked with the founder of a website that's signing up volunteers to participate in HCTs, and one of the more than 25,000 people who have signed up to consider volunteering. But what do the scientists and researchers involved in making vaccines think about using HCTs? Dr. David Weiner, director of the Wistar Institute's Vaccine and Immunology Center joins KYW In Depth to talk about the ethics and logistics of Human Challenge Trials from the point of view of a vaccine developer. Part 1: Should HCTs be used for coronavirus? https://bit.ly/2XeyrIi Part 2: Why would someone volunteer for an HCT? https://bit.ly/3gC7iqn See omnystudio.com/policies/listener for privacy information.

To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy

Learn more about your ad choices. Visit https://podcastchoices.com/adchoices